Introduction
A multidisciplinary research team from Cleveland Clinic, Japan's RIKEN institute and IBM has been named a finalist for the 2026 ACM Gordon Bell Prize, often described as the Nobel Prize of supercomputing, for simulating the largest biologically meaningful molecule ever modeled using quantum computers. The team's work, announced on September 9, 2026, involved modeling a protein-ligand system spanning 12,635 atoms, a scale previously considered far beyond the reach of quantum-enabled simulation.
What the Team Achieved
The research combined IBM's Quantum Heron processors with three major supercomputers, Japan's Fugaku, RIKEN's new ROQUO system and the University of Tokyo's Miyabi-G, to model a trypsin protein bound to a ligand and submerged in water. The achievement builds on earlier work first published in May 2026, when the same team reported the first-known quantum simulation of a much smaller 303-atom protein, before scaling their method roughly 40 times in size while also achieving a 210-fold improvement in accuracy.
Key Facts
- The team simulated a 12,635-atom protein-ligand system, the largest of its kind using quantum computers.
- The work combines IBM Quantum Heron processors with the Fugaku, ROQUO and Miyabi-G supercomputers.
- Earlier work in May 2026 simulated a 303-atom protein before scaling up roughly 40 times.
- The team reported a 210-fold improvement in accuracy alongside the scale-up.
- The Gordon Bell Prize winner will be announced at the SC26 conference in Chicago in November 2026.
Why This Matters for Drug Discovery
The research specifically targets improved accuracy in calculating protein-ligand binding energy, a measurement that reflects how tightly two molecules bind together and helps predict how a potential drug compound might interact with a specific protein target in the body. More accurate binding energy calculations could meaningfully reduce the time and cost involved in early-stage drug discovery, where researchers currently rely heavily on classical computational methods that struggle to model molecular interactions at this level of complexity and scale.
Table: Project Milestones
| Milestone | Detail |
|---|---|
| First Simulation (May 2026) | 303-atom protein modeled using quantum computers |
| Scale-Up | Roughly 40x increase in system size |
| Accuracy Improvement | 210x improvement in binding energy calculation accuracy |
| Latest Result (September 2026) | 12,635-atom trypsin-ligand system simulated |
The Technical Approach
The team used a technique called sample-based quantum diagonalization, developed jointly by IBM and RIKEN and previously featured on the cover of the journal Science Advances, combined with embedded wavefunction methods adapted specifically by Cleveland Clinic researchers for this molecular system. A newly introduced fully automated end-to-end workflow, running on RIKEN's ROQUO supercomputer, reduces the manual coordination and data movement previously required between quantum and classical computing resources, a practical engineering advance that complements the underlying scientific breakthrough.
Expert Insight
Dr. Kenneth Merz, a staff scientist in Cleveland Clinic's Computational Life Sciences Department, said when the underlying research first published that the work marks an important advance showing quantum computing's emerging role on systems relevant to drug discovery. Researchers in the field note that while quantum-centric supercomputing remains far from replacing classical methods entirely for most pharmaceutical applications, results like this demonstrate a credible, steadily improving pathway toward quantum computers playing a meaningful role in computational chemistry within the coming years, rather than remaining a purely theoretical possibility.
Key Takeaways
- IBM, Cleveland Clinic and RIKEN are Gordon Bell Prize finalists for a record 12,635-atom quantum protein simulation.
- The work combines quantum processors with three major supercomputers across the US, Japan and international collaboration.
- The team achieved a 40x scale-up and 210x accuracy improvement compared with earlier work.
- The winner of the 2026 Gordon Bell Prize will be announced at SC26 in Chicago in November.
FAQ
What is the Gordon Bell Prize?
It is one of the most prestigious awards in supercomputing, often described as the field's equivalent of a Nobel Prize, recognising breakthrough achievements in high-performance computing.
How large was the protein system simulated?
The team modeled a 12,635-atom protein-ligand system, the largest biologically meaningful molecule ever simulated using quantum computers.
Why is this research significant for medicine?
Improved protein-ligand binding energy calculations could help researchers more accurately predict how potential drug compounds interact with target proteins, potentially speeding up early-stage drug discovery.
Conclusion
Whether or not the team ultimately wins the 2026 Gordon Bell Prize when results are announced in November, the achievement itself marks a meaningful step in demonstrating that quantum-centric supercomputing is moving from proof-of-concept demonstrations toward genuinely useful scale for real-world computational chemistry problems.
